Primary Hyperparathyroidism in Patients With Breast Carcinoma
- 1 November 1970
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 101 (5), 582-585
- https://doi.org/10.1001/archsurg.1970.01340290038008
Abstract
Hypercalcemia is frequently observed in patients with breast carcinoma. When the biochemical effects of osteolytic metastases, hormonal therapy, or other pathological states are ruled out, simultaneous hyperparathyroidism must be considered. Six women with breast cancer were found to have anatomic parathyroid gland changes. Two of these patients showed hyperplasia. In one patient all of the parathyroid glands were involved, and in the other patient a single adenomatous gland was removed. The hyperparathyroidism of the latter patient disappeared postoperatively. In four of these patients a single adenoma was found. Their removal in three instances was associated with the disappearance of hyperparathyroidism. The fourth adenoma was found at necropsy.This publication has 11 references indexed in Scilit:
- Hypercalcemia and MalignancyPublished by Bentham Science Publishers Ltd. ,2012
- Hypercalcemia associated with estrogen administration in patients with breast carcinomaCancer, 1969
- A study of urinary excretion of parathyroid hormone in manJournal of Clinical Investigation, 1968
- The parathyroid oxyphil cellsJournal of Clinical Pathology, 1967
- PSEUDOHYPERPARATHYROIDISMMedicine, 1966
- Pseudohyperparathyroidism due to malignant tumorsCancer, 1964
- HYPERCALCEMIA OF MALIGNANT DISEASE: CASE REPORT AND A PROPOSED MECHANISM OF ETIOLOGYAnnals of Internal Medicine, 1961
- A study of the epidemiology of cancer of the breastCancer, 1960
- Hypercalcemia in Neoplastic DiseaseArchives of Surgery, 1960
- Primary hyperparathyroidism and metastatic breast carcinoma: A case in which breast carcinoma metastasized to a parathyroid adenomaCancer, 1958